292 related articles for article (PubMed ID: 26044819)
21. Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial.
Mathian A; Pha M; Haroche J; Cohen-Aubart F; Hié M; Pineton de Chambrun M; Boutin THD; Miyara M; Gorochov G; Yssel H; Cherin P; Devilliers H; Amoura Z
Ann Rheum Dis; 2020 Mar; 79(3):339-346. PubMed ID: 31852672
[TBL] [Abstract][Full Text] [Related]
22. An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort.
Watson P; Brennan A; Birch H; Fang H; Petri M
Rheumatology (Oxford); 2015 Apr; 54(4):623-32. PubMed ID: 25234659
[TBL] [Abstract][Full Text] [Related]
23. Prednisone and long-term damage in systemic lupus erythematosus: Which is the threshold dose? A pilot study.
Danza A; Graña D; Soto E; Silveira G; Carlomagno A; Rebella M
Lupus; 2022 Jun; 31(7):880-884. PubMed ID: 35354060
[TBL] [Abstract][Full Text] [Related]
24. Damage in systemic lupus erythematosus and its association with corticosteroids.
Zonana-Nacach A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870
[TBL] [Abstract][Full Text] [Related]
25. Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.
Zeña-Huancas PA; Iparraguirre-López H; Gamboa-Cárdenas RV; Reátegui-Sokolova C; Zevallos-Miranda F; Medina-Chinchon M; Pimentel-Quiroz VR; Elera-Fitzcarrald C; Sarmiento-Velasquez O; Cucho-Venegas JM; Alfaro-Lozano JL; Rodríguez-Bellido ZJ; Pastor-Asurza CA; Perich-Campos RA; Alarcón GS; Ugarte-Gil MF
Clin Rheumatol; 2019 Apr; 38(4):1139-1146. PubMed ID: 30539353
[TBL] [Abstract][Full Text] [Related]
26. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.
Brunner HI; Jones OY; Lovell DJ; Johnson AM; Alexander P; Klein-Gitelman MS
Lupus; 2003; 12(8):600-6. PubMed ID: 12945718
[TBL] [Abstract][Full Text] [Related]
27. Predictors of corticosteroid tapering in SLE patients: the Hopkins Lupus Cohort.
Zahr ZA; Fang H; Magder LS; Petri M
Lupus; 2013 Jun; 22(7):697-701. PubMed ID: 23708944
[TBL] [Abstract][Full Text] [Related]
28. Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Quintana R; Gómez-Puerta JA; Catoggio LJ; Alvarellos A; Saurit V; Borba E; Sato E; Costallat L; Da Silva NA; Iglesias-Gamarra A; Neira O; Reyes-Llerena G; Cardiel MH; Amigo MC; Acevedo-Vásquez E; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA
J Rheumatol; 2019 Oct; 46(10):1299-1308. PubMed ID: 30824636
[TBL] [Abstract][Full Text] [Related]
29. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
Kim SK; Choe JY; Lee SS
J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
[TBL] [Abstract][Full Text] [Related]
30. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
Sato JO; Corrente JE; Saad-Magalhães C
Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
[TBL] [Abstract][Full Text] [Related]
31. Accrual of organ damage over time in patients with systemic lupus erythematosus.
Gladman DD; Urowitz MB; Rahman P; Ibañez D; Tam LS
J Rheumatol; 2003 Sep; 30(9):1955-9. PubMed ID: 12966597
[TBL] [Abstract][Full Text] [Related]
32. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
[TBL] [Abstract][Full Text] [Related]
33. Independent association of glucocorticoids with damage accrual in SLE.
Apostolopoulos D; Kandane-Rathnayake R; Raghunath S; Hoi A; Nikpour M; Morand EF
Lupus Sci Med; 2016; 3(1):e000157. PubMed ID: 27933196
[TBL] [Abstract][Full Text] [Related]
34. Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial.
Ordi-Ros J; Sáez-Comet L; Pérez-Conesa M; Vidal X; Mitjavila F; Castro Salomó A; Cuquet Pedragosa J; Ortiz-Santamaria V; Mauri Plana M; Cortés-Hernández J
Ann Rheum Dis; 2017 Sep; 76(9):1575-1582. PubMed ID: 28450313
[TBL] [Abstract][Full Text] [Related]
35. Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Medium-to-High-Dose Glucocorticoids.
Kim MH; Choi SR; Park JK; Lee EY; Lee EB; Park JW
Lupus; 2023 Apr; 32(5):625-632. PubMed ID: 36858809
[TBL] [Abstract][Full Text] [Related]
36. Real-world use and outcomes of belimumab in childhood-onset lupus: A single-center retrospective study.
Roberts JE; Burn C; Sadun RE; Smitherman EA; Wenderfer SE; Son MBF
Lupus; 2023 Aug; 32(9):1111-1116. PubMed ID: 37410059
[TBL] [Abstract][Full Text] [Related]
37. Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL).
Reátegui-Sokolova C; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Serrano-Morales RM; Sacnun MP; Catoggio LJ; Soriano ER; García MA; Saurit V; Alvarellos A; Caeiro F; Berbotto GA; Sato EI; Borba Neto EF; Bonfa E; de Oliveira E Silva Montandon AC; Da Silva NA; Cavalcanti F; Vásquez G; Guibert-Toledano M; Reyes-Llerena GA; Massardo L; Neira OJ; Cardiel MH; Barile-Fabris LA; Amigo MC; Silveira LH; Portela-Hernández M; Garcia de la Torre I; Segami MI; Chacón-Diaz R; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA;
RMD Open; 2020 Dec; 6(3):. PubMed ID: 33310863
[TBL] [Abstract][Full Text] [Related]
38. Active lupus in Argentina: Results of a multicenter and national registry.
Quintana RM; García M; Garcia L; Gobbi C; Alba P; Bellomio V; Roverano S; Alvarez AP; Graf CE; Pisoni C; Spindler A; Gomez C; Figueredo HM; Papasidero S; Paniego R; de la Vega MC; Civit E; Gonzalez Lucero L; Martire MV; Aguila Maldonado R; Gordon S; Micelli M; Nieto R; Rausch G; Alarcón GS; Pons-Estel B; Pons-Estel G;
Lupus; 2023 Nov; 32(13):1555-1560. PubMed ID: 37936393
[TBL] [Abstract][Full Text] [Related]
39. Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.
Garcia-Carrasco M; Mendoza-Pinto C; Sandoval-Cruz M; Soto-Vega E; Beltran-Castillo A; Jimenez-Hernandez M; Graillet D; Gonzalez L; Rojas-Rodriguez J; Pineda-Almazana A; Zamudio-Huerta L; Lopez-Colombo A
Lupus; 2010 Feb; 19(2):213-9. PubMed ID: 19965944
[TBL] [Abstract][Full Text] [Related]
40. [The effect of long-term low dose prednisone on bone mineral density in patients with systemic lupus erythematosus].
Wang G; Li XP; Li XM; Wang GS; Tao JH; Ma Y
Zhonghua Nei Ke Za Zhi; 2017 Mar; 56(3):179-183. PubMed ID: 28253597
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
